Published: 1 March 2019
Committees
Agenda for the 177th meeting of the Medicines Adverse Reactions Committee to be held on Thursday 14 March 2019, at 9 am
				1. | 
				
				MATTERS OF ADMINISTRATION | 
			
				1.1 | 
				
				Welcome and apologies | 
			
				1.2 | 
				
				Minutes and recommendations of the 176th MARC meeting | 
			
				1.3 | 
				
				Declarations of potential conflicts of interest | 
			
				2. | 
				
				MATTERS ARISING FROM THE NZ PHARMACOVIGILANCE CENTRE | 
			
				2.1 | 
				
				CARM quarterly report | 
			
				3. | 
				
				PHARMACOVIGILANCE REPORTS | 
			
				3.1 | 
				
				Matters referred to the MARC under section 36 of the Medicines Act 1981 | 
			
| No items | |
				3.2 | 
				
				Matters referred to the MARC by Medsafe | 
			
| 3.2.1 Fingolimod and tumefactive lesions | |
| 3.2.2 NSAIDs - an update on CVD risk | |
| 3.2.3 Use of methadone in breastfeeding | |
| 3.2.4 Update on nitrofurantoin use in renal impairment | |
| 3.2.5 Ergotamine containing medicines and pancreatitis | |
				4. | 
				
				MEDSAFE PHARMACOVIGILANCE ACTIVITIES | 
			
				4.1 | 
				
				Report on standing agenda items | 
			
				4.2 | 
				
				Medsafe pharmacovigilance activities | 
			
				4.3 | 
				
				Prescriber Update | 
			
				4.4 | 
				
				Quarterly summary of recent safety communications | 
			
				5. | 
				
				OTHER BUSINESS | 
			





